by Liliana Resende | Jul 8, 2021 | News
Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...
by Liliana Resende | Mar 10, 2021 | News
In the largest study of its kind to date, the UK’s International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the...
by Eamonn | Oct 27, 2020 | Research
Associated clinical studies in COVID-19 The emergence of the novel coronavirus (SARS-CoV-2) in December 2019 caused a pandemic of a severe coronavirus disease, COVID-19, that has become the main focus of several research projects. ISARIC has many member networks, who...
by Eamonn | Oct 23, 2020 | Research
COVID-19 Long term follow up study As time passes, researchers and clinicians face the unknown; the health and wellbeing of patients who recovered from COVID-19. ISARIC Global COVID-19 follow-up working group, in collaboration with the WHO and a range of experts,...
